ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Financial Planning & Analysis Manager at Gossamer Bio - ApplyBlast

Financial Planning & Analysis Manager

Gossamer Bio

3 months ago

San Diego, California, United States

Hybrid

Full Time

Senior

5 applicants

View Job Listing

Apply to 100+ jobs

About this role

The FP&A Manager leads financial planning, forecasting, and performance analysis to support commercial and go-to-market initiatives across the organization. This role serves as a key business partner to sales and marketing leadership, building scalable processes and delivering actionable insights for executive decision-making. The position requires a strategic thinker with hands-on experience in financial modeling and reporting within a fast-paced startup environment.

Responsibilities

Lead annual budget planning and quarterly re-forecasting processes
Build dynamic financial models to support short- and long-term planning
Partner with commercial teams to provide real-time financial insights
Prepare monthly and quarterly reporting packages for executive leadership
Drive automation of reporting and analytics to improve efficiency

Skills

Qualifications

Bachelor's degree in Finance, Accounting, EconomicsCPA preferredMBA preferred

About Gossamer Bio

gossamerbio.com

Headquarters

San Diego, California, United States

Company Size

51-200 employees

Founded

2017

View Profile

Gossamer Bio is a clinical-stage biopharmaceutical company focused on the development of seralutinib, an investigational inhaled PDGFRα/β, CSF1R, and c-KIT inhibitor delivered via dry powder inhaler, for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company's lead program is currently being evaluated in the PROSERA Study, a Phase 3 clinical trial in adults with PAH. Gossamer Bio is committed to improving the lives of patients with these rare diseases.